Analyst Reco. Silk Road Medical, Inc

Equities

SILK

US82710M1009

Market Closed - Nasdaq Other stock markets 21:00:00 20/05/2024 BST			5-day change	1st Jan Change
22.74 ^USD	+2.52%		+9.75%	+85.33%

05-15	Transcript : Silk Road Medical, Inc Presents at Bank of America Health Care Conference 2024, May-14-2024 through May-16-2024
04-30	Transcript : Silk Road Medical, Inc, Q1 2024 Earnings Call, Apr 30, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Argus Upgrades Silk Road Medical to Buy From Hold, Price Target is $24	03-07	MT
Piper Sandler Raises Price Target on Silk Road Medical to $18 From $11, Maintains Neutral Rating	02-29	MT
Stifel Upgrades Silk Road Medical to Buy From Hold, Raises Price Target to $20 From $9	01-19	MT
Lake Street Initiates Silk Road Medical at Buy Rating With $20 Price Target	01-03	MT
Oppenheimer Adjusts Silk Road Medical Price Target to $25 From $30, Maintains Outperform Rating	11-09	MT
Wolfe Research Upgrades Silk Road Medical to Peer Perform From Underperform	24/10/23	MT
BofA Lowers Price Target on Silk Road Medical to $8 From $28, Keeps Underperform Rating	18/10/23	MT
Piper Sandler Lowers Price Target on Silk Road Medical to $11 From $25, Maintains Neutral Rating	11/10/23	MT
B. Riley Downgrades Silk Road Medical to Neutral From Buy, Lowers Price Target to $14 From $54	11/10/23	MT
CL King Downgrades Silk Road Medical to Neutral From Buy	11/10/23	MT
Nephron Research Downgrades Silk Road Medical to Hold From Buy, Adjusts Price Target to $10 From $37	11/10/23	MT
Citigroup Downgrades Silk Road Medical to Sell From Buy, Cuts Price Target to $8 From $35	11/10/23	MT
Stifel Downgrades Silk Road Medical to Hold From Buy, Cuts Price Target to $12 From $45	11/10/23	MT
Argus Research Downgrades Silk Road Medical to Hold From Buy	21/09/23	MT
Oppenheimer Initiates Coverage on Silk Road Medical With Outperform Rating, $30 Price Target	06/09/23	MT
Citigroup Cuts Price Target on Silk Road Medical to $35 From $48, Maintains Buy Rating	14/08/23	MT
Stifel Adjusts Price Target on Silk Road Medical to $45 From $50, Maintains Buy Rating	02/08/23	MT
B. Riley Lowers Silk Road Medical's PT to $54 From $58, Keeps Buy Rating	02/08/23	MT
BofA Securities Downgrades Silk Road Medical to Underperform From Buy, Adjusts Price Target to $28 From $51	12/07/23	MT
JPMorgan Downgrades Silk Road Medical to Neutral From Overweight, Cuts Price Target to $28 From $50	12/07/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Silk Road Medical, Inc

Equities

SILK

US82710M1009

Analyst Reco.

Filters